This guideline covers interventions in the acute stage of a stroke or transient ischaemic attack (TIA).
Amgen announced results from a new Repatha (evolocumab) economic analysis published in the Journal of the American Medical Association (JAMA)...
Objective: In addition to achieving glycemic control, weight loss and blood pressure reduction are important components of type 2 diabetes mellitus management, as many patients with T2DM are overweight/obese and/or have hypertension.
In the past decade, the definition of stroke has been revised and major advances have been made for its treatment and prevention.
AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke or high-risk transient ischaemic attack (TIA).
Thrombolytic treatment in acute myocardial infarction - 90 minutes (accelerated) dose regimen (see section 4.2): for patients in whom treatment can be started within 6 hours after symptom onset - 3 hour dose regimen (see section 4.2): for patients in whom treatment can be started between 6 - 12 hours after symptom onset provided that the diagnosis has been clearly confirmed. Actilyse has proven to reduce 30-day-mortality in patients with acute myocardial infarction. Thrombolytic treatment in acute massive pulmonary embolism with haemodynamic instability The diagnosis should be confirmed whenever possible by objective means such as pulmonary angiography or non-invasive procedures such as lung scanning. There is no evidence for positive effects on mortality and late morbidity related to pulmonary embolism. Fibrinolytic treatment of acute ischaemic stroke Treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging techniques (e.g. cranial computerised tomography or other diagnostic imaging method sensitive for the presence of haemorrhage). The treatment effect is time-dependent; therefore earlier treatment increases the probability of a favourable outcome.
In Uganda, biomass smoke seems to be the largest risk factor for the development of COPD, but socio-economic factors and gender may have a role. Therefore, more in-depth research is needed to understand the risk factors.
The UK National Institute for Health and Care Excellence (NICE) guidelines state that carotid endarterectomy should be scheduled within 2 weeks of symptoms. The recent National Stroke Strategy has reduced the time interval to 48 h.
A new analysis of real-world data has shown that switching to Tresiba (insulin degludec) is highly cost-effective and cost-saving for...
PharmaEssentia USA Corp announced the publication of a cost-effectiveness analysis of Besremi (ropeginterferon alfa-2b-njft) in the Journal of Comparative Effectiveness Research.